FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385064103> ?p ?o ?g. }

• W4385064103 endingPage "1501" @default.
• W4385064103 startingPage "1493" @default.
• W4385064103 abstract "Ceramides are lipid molecules involved in inflammation-related signaling. Recent studies have shown that higher amounts of specific circulating ceramides and their ratios are associated with future development of cardiovascular (CV) disease (CVD). We examined the associations between serum ceramide levels with CVD, kidney failure, and all-cause mortality in individuals with long-standing type 1 diabetes (T1D). We included 662 participants with T1D and 6-year follow-up, with a mean age of 55 years and mean diabetes duration of 33 years. Baseline serum samples were analyzed using liquid chromatography–mass spectrometry. Six predefined ceramide levels were measured, and predefined ratios were calculated. Adjusted Cox regression analyses on ceramide levels in relation to future CV events (CVE), kidney failure, and all-cause mortality were performed, with and without adjustment for age, sex, BMI, LDL, triglycerides, systolic blood pressure, HbA1c, history of CVD, smoking status, statin use, estimated glomerular filtration rate (eGFR), and urinary albumin excretion rate (UAER). The ceramide ratio cer(d18:1/18:0)/cer(d18:1/24:0) was significantly associated with risk of CVE (hazard ratio [HR] = 1.33, P = 0.01) and all-cause mortality (HR = 1.48, P = 0.01) before and after adjustments. All five investigated ceramide ratios were associated with kidney failure, before adjusting for the kidney markers eGFR and UAER. In this study, we demonstrate specific ceramides and ratios associated with 6-year cardiovascular risk and all-cause mortality in a T1D cohort. This highlights the strength of ceramide association with vascular complications and presents a new potential tool for early risk assessment if validated in other cohorts. Article Highlights Improved tools for assessing risk for diabetes complication before onset will help in complication prevention. We investigated a set of six predefined ceramides and their ratios versus 6-year outcomes of cardiovascular events, kidney failure, and all-cause mortality in people with long-standing type 1 diabetes, using Cox regression with and without adjustment for potential confounders. We found that several ceramides and ceramide ratios associated with cardiovascular events and all-cause mortality. The ratio of cer(d18:1/18:0)/cer(d18:1/24:0) was an especially robust marker. These finding show that ceramides can be biomarkers of cardiovascular disease and all-cause mortality in individuals with long-standing type 1 diabetes." @default.
• W4385064103 created "2023-07-23" @default.
• W4385064103 creator A5003040516 @default.
• W4385064103 creator A5004120950 @default.
• W4385064103 creator A5011475028 @default.
• W4385064103 creator A5041442093 @default.
• W4385064103 creator A5045907715 @default.
• W4385064103 creator A5061864636 @default.
• W4385064103 creator A5064636487 @default.
• W4385064103 creator A5069948018 @default.
• W4385064103 creator A5072393536 @default.
• W4385064103 creator A5074649341 @default.
• W4385064103 date "2023-07-21" @default.
• W4385064103 modified "2023-10-05" @default.
• W4385064103 title "Ceramides as risk markers for future cardiovascular events and all-cause mortality in long-standing type 1 diabetes" @default.
• W4385064103 cites W1797739168 @default.
• W4385064103 cites W1989299822 @default.
• W4385064103 cites W2008661724 @default.
• W4385064103 cites W2020740038 @default.
• W4385064103 cites W2036157542 @default.
• W4385064103 cites W2100198908 @default.
• W4385064103 cites W2101634568 @default.
• W4385064103 cites W2102924526 @default.
• W4385064103 cites W2114597064 @default.
• W4385064103 cites W2147108549 @default.
• W4385064103 cites W2147944809 @default.
• W4385064103 cites W2154979016 @default.
• W4385064103 cites W2168526937 @default.
• W4385064103 cites W2344273352 @default.
• W4385064103 cites W2537149664 @default.
• W4385064103 cites W2537881633 @default.
• W4385064103 cites W2538517030 @default.
• W4385064103 cites W2557359439 @default.
• W4385064103 cites W2563394241 @default.
• W4385064103 cites W2609543937 @default.
• W4385064103 cites W2767518162 @default.
• W4385064103 cites W2794877394 @default.
• W4385064103 cites W2800320377 @default.
• W4385064103 cites W2804968486 @default.
• W4385064103 cites W2805964818 @default.
• W4385064103 cites W2808313808 @default.
• W4385064103 cites W2887373570 @default.
• W4385064103 cites W2890371182 @default.
• W4385064103 cites W2894993577 @default.
• W4385064103 cites W2908779813 @default.
• W4385064103 cites W2940888331 @default.
• W4385064103 cites W2948192940 @default.
• W4385064103 cites W2965475701 @default.
• W4385064103 cites W2966614842 @default.
• W4385064103 cites W2972530371 @default.
• W4385064103 cites W2982645614 @default.
• W4385064103 cites W2985106817 @default.
• W4385064103 cites W2988194888 @default.
• W4385064103 cites W3003573827 @default.
• W4385064103 cites W3016049747 @default.
• W4385064103 cites W3046753361 @default.
• W4385064103 cites W3080886764 @default.
• W4385064103 cites W3097883702 @default.
• W4385064103 cites W3123009288 @default.
• W4385064103 cites W3136668199 @default.
• W4385064103 cites W3158165514 @default.
• W4385064103 cites W3194573471 @default.
• W4385064103 cites W4220707407 @default.
• W4385064103 cites W4253996779 @default.
• W4385064103 cites W4285727333 @default.
• W4385064103 doi "https://doi.org/10.2337/db23-0052" @default.
• W4385064103 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37478203" @default.
• W4385064103 hasPublicationYear "2023" @default.
• W4385064103 type Work @default.
• W4385064103 citedByCount "0" @default.
• W4385064103 crossrefType "journal-article" @default.
• W4385064103 hasAuthorship W4385064103A5003040516 @default.
• W4385064103 hasAuthorship W4385064103A5004120950 @default.
• W4385064103 hasAuthorship W4385064103A5011475028 @default.
• W4385064103 hasAuthorship W4385064103A5041442093 @default.
• W4385064103 hasAuthorship W4385064103A5045907715 @default.
• W4385064103 hasAuthorship W4385064103A5061864636 @default.
• W4385064103 hasAuthorship W4385064103A5064636487 @default.
• W4385064103 hasAuthorship W4385064103A5069948018 @default.
• W4385064103 hasAuthorship W4385064103A5072393536 @default.
• W4385064103 hasAuthorship W4385064103A5074649341 @default.
• W4385064103 hasBestOaLocation W43850641031 @default.
• W4385064103 hasConcept C126322002 @default.
• W4385064103 hasConcept C134018914 @default.
• W4385064103 hasConcept C159641895 @default.
• W4385064103 hasConcept C190283241 @default.
• W4385064103 hasConcept C207103383 @default.
• W4385064103 hasConcept C2776174234 @default.
• W4385064103 hasConcept C2777180221 @default.
• W4385064103 hasConcept C2777851122 @default.
• W4385064103 hasConcept C2778653478 @default.
• W4385064103 hasConcept C2780221984 @default.
• W4385064103 hasConcept C2780306776 @default.
• W4385064103 hasConcept C44249647 @default.
• W4385064103 hasConcept C50382708 @default.
• W4385064103 hasConcept C55493867 @default.
• W4385064103 hasConcept C555293320 @default.
• W4385064103 hasConcept C71924100 @default.

• next